Search research articles
Contact Us
Filters
Showing results (351-360 of 368) with videos related to
Page
of 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2011
Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma
Matthew J Maurer, Ivana N M Micallef, James R Cerhan, et al.
Journal for Immunotherapy of Cancer
|
June 29, 2023
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas
Andrew L Coveler, David C Smith, Tycel Phillips, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Patricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Investigative Ophthalmology & Visual Science
|
November 27, 2024
Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research
Lauren A Dalvin, Cynthia M Andrews-Pfannkoch, David R Miley, et al.
Nature Communications
|
February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Frontiers in Immunology
|
November 29, 2023
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses
Katherine E R Smith, Kah-Whye Peng, Jose S Pulido, et al.
Blood
|
July 5, 2011
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
Thomas E Witzig, Hui Tang, Ivana N M Micallef, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2018
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma
Aaron S Mansfield, Tobias Peikert, James B Smadbeck, et al.
Nature Communications
|
March 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial
Jacob J Orme, Henan Zhang, Prashanth Lingamaneni, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 368) with videos related to
Sort By:
Page
of 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2011
Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma
Matthew J Maurer, Ivana N M Micallef, James R Cerhan, et al.
Journal for Immunotherapy of Cancer
|
June 29, 2023
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas
Andrew L Coveler, David C Smith, Tycel Phillips, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Patricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Investigative Ophthalmology & Visual Science
|
November 27, 2024
Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research
Lauren A Dalvin, Cynthia M Andrews-Pfannkoch, David R Miley, et al.
Nature Communications
|
February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Frontiers in Immunology
|
November 29, 2023
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses
Katherine E R Smith, Kah-Whye Peng, Jose S Pulido, et al.
Blood
|
July 5, 2011
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
Thomas E Witzig, Hui Tang, Ivana N M Micallef, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2018
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma
Aaron S Mansfield, Tobias Peikert, James B Smadbeck, et al.
Nature Communications
|
March 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial
Jacob J Orme, Henan Zhang, Prashanth Lingamaneni, et al.
Page
of 37